Dive Into Dollar Tr...
Health Care: Drugs
GTx Inc. (GTXI: NASDAQ)
$5.66 0.11 | 1.98%
05/17/13 - 04:00 PM ET
Portfolios with GTXI
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserJRC'S PICKS
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ContributorHot Biotech Trades for Seco...
- ContributorStocks With Big Insider Buy...
- Contributor10 Cheap Biotech Stocks Tha...
- UserRimp's Stockpicks
Latest GTXI Headlines from TheStreet
- 5 Health Care Stocks Under $10 Ready to Rip Higher 04.18.13 | 09:04 pm
- 4 Stocks Soaring on Unusual Volume 12.11.12 | 03:12 pm
- 5 Biotech Stocks Under $10 Blasting Higher 08.14.12 | 03:08 pm
- GTx's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.08.12 | 03:08 pm
- 7 Stocks Soaring in a Weak Market 05.08.12 | 02:05 pm
- 5 Stocks Insiders Love Right Now 03.15.12 | 01:03 pm
- Insiders Trading AMAG, CLWR, GTXI 03.06.12 | 10:03 am
- GTx Stock Gaps Down On Today's Open (GTXI) 02.21.12 | 08:02 am
- 5 Stocks With Big Insider Buying 07.01.11 | 02:07 pm
- Insiders Trading KIOR, NWN, GTXI 06.29.11 | 10:06 am
Press Releases for GTXI
- GTx-758 Poster Presentation Of Phase II Trial Data In Advanced Prostate Cancer Selected As One Of The Best Posters At The 28th Annual European Association Of Urology Congress - Business Wire 03.19.13 | 08:03 am
- Enobosarm Phase 2 Trial For Muscle Wasting And Physical Function In Patients With Cancer Published In The Lancet Oncology - Business Wire 03.14.13 | 07:03 am
- GTx Announces Webcast Of Corporate Presentation At Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.27.13 | 07:02 am
- GTx Provides Corporate Update And Reports 2012 Financial Results - Business Wire 02.21.13 | 06:02 am
- GTx Announces Webcast Of Corporate Presentation At 2013 Citi Global Healthcare Conference - Business Wire 02.19.13 | 07:02 am
- GTx To Present Preclinical Data On A New Therapeutic Target In Prostate Cancer - Business Wire 02.14.13 | 07:02 am
- Novel Findings From Clinical Studies Examining The Effects Of Capesaris® (GTx-758) For The Treatment Of Advanced Prostate Cancer To Be Presented At 2013 American Society Of Clinical Oncology Genitourinary Cancer Symposium - Business Wire 02.13.13 | 07:02 am
- GTx Announces Webcast For Capesaris®(GTx-758) Analyst Day - Business Wire 02.12.13 | 07:02 am
- GTx, Inc. To Host Fourth Quarter And Full Year 2012 Financial Results Conference Call And Webcast - Business Wire 02.07.13 | 07:02 am
- GTx Announces Webcast Of Corporate Presentation At Bio CEO & Investor Conference - Business Wire 02.05.13 | 07:02 am
Partner Headlines for GTXI
- Near-Term Catalysts And High Insider Ownership Make GTx An Attractive Buy - Seeking Alpha 05.07.13 | 09:05 am
- Weekly CEO Sells Highlight: GTx, Inc, VIVUS, Inc, Time Warner Inc. - GuruFocus 07.23.12 | 01:07 am
- 3 Rallying Stocks Under $5 Being Bought Up By Company Insiders - Seeking Alpha 07.22.12 | 09:07 am
- Analyzing GTx, Inc.'s Vast Upside Potential - Seeking Alpha 03.26.12 | 09:03 am
- Will the Next Apple or Google Be Found Among These Micro Caps? - Seeking Alpha 08.18.11 | 09:08 am
- Calls Purchased on GTx, Inc. - Benzinga 06.20.11 | 01:06 pm
- 7 Small-Cap Biotechs With Bullish Insider Buying in 2011 - Seeking Alpha 06.12.11 | 05:06 am
- 6 Stocks With New Uptrends - Seeking Alpha 05.26.11 | 07:05 am
- Company News for April 14, 2011 - Corporate Summary - Zacks 04.14.11 | 10:04 am
- GTx Up Nearly 26% (GTXI) - Benzinga 04.13.11 | 09:04 am
